Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Gastroenterology

Volumn 155, Issue 2, 2018, Pages 307-310.e2

  Ajmera, Veeral ^a   Park, Charlie C ^a   Caussy, Cyrielle ^a,b   Singh, Seema ^a   Hernandez, Carolyn ^a   Bettencourt, Ricki ^a   Hooker, Jonathan ^c   Sy, Ethan ^c   Behling, Cynthia ^d   Xu, Ronghui ^e   Middleton, Michael S ^c   Valasek, Mark A ^f   Faulkner, Claire ^a   Rizo, Emily ^a   Richards, Lisa ^a   Sirlin, Claude B ^b   Loomba, Rohit ^a,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Sharp Medical Group   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomarker; NASH; Risk Factor; Steatosis

Indexed keywords

TRIACYLGLYCEROL; BIOLOGICAL MARKER; PROTON;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE EXACERBATION; ETHNICITY; FAT CONTENT; FEMALE; FOLLOW UP; GENETIC VARIATION; HUMAN; HUMAN TISSUE; LIVER; LIVER BIOPSY; LIVER FIBROSIS; LIVER STIFFNESS; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ADIPOSE TISSUE; AGED; BIOPSY; DIAGNOSTIC IMAGING; LIVER CIRRHOSIS; LIVER FUNCTION TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

ADIPOSE TISSUE; ADULT; AGED; BIOMARKERS; BIOPSY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PROTONS;

EID: 85049790211     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2018.04.014     Document Type: Article

References (31)

1. Kleiner, D.E., et al. Hepatology 41 (2005), 1313–1321.
2. Le, T.A., et al. Hepatology 56 (2012), 922–932.
3. Park, C.C., et al. Gastroenterology 152 (2017), 598–607.e2.
4. Mashhood, A., et al. J Magn Reson Imaging 37 (2013), 1359–1370.
5. Loomba, R., et al. Hepatology 61 (2015), 1239–1250.
6. Ekstedt, M., et al. Hepatology 61 (2015), 1547–1554.
7. Angulo, P., et al. Gastroenterology 149 (2015), 389–397.e10.
8. Dulai, P.S., et al. Hepatology 65 (2017), 1557–1565.
9. Romeo, S., et al. Nat Genet 40 (2008), 1461–1465.
10. Rotman, Y., et al. Hepatology 52 (2010), 894–903.
11. Kozlitina, J., et al. Nat Genet 46 (2014), 352–356.
12. Liu, Y.L., et al. Nat Commun, 5, 2014, 4309.
13. Lallukka, S., et al. Sci Rep, 7, 2017, 14561.
14. Unalp-Arida, A., et al. Hepatology 63 (2016), 1170–1183.
15. Singh, S., et al. Clin Gastroenterol Hepatol 13 (2015), 643–654.e1–9.
16. Le, T.A., Chen, J., Changchien, C., et al. Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology 56 (2012), 922–932.
17. Loomba, R., Sirlin, C.B., Ang, B., et al. Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology 61 (2015), 1239–1250.
18. Loomba, R., Schork, N., Chen, C.H., et al. Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study. Gastroenterology 149 (2015), 1784–1793.
19. Doycheva, I., Cui, J., Nguyen, P., et al. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE. Aliment Pharmacol Ther 43 (2016), 83–95.
20. Loomba, R., Cui, J., Wolfson, T., et al. Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study. Am J Gastroenterol 111 (2016), 986–994.
21. Kleiner, D.E., Brunt, E.M., Van Natta, M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005), 1313–1321.
22. Neuschwander-Tetri, B.A., Loomba, R., Sanyal, A.J., et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet 385 (2015), 956–965.
23. Tang, A., Desai, A., Hamilton, G., et al. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 274 (2015), 416–425.
24. Tang, A., Tan, J., Sun, M., et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267 (2013), 422–431.
25. Reeder, S.B., Robson, P.M., Yu, H., et al. Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imaging 29 (2009), 1332–1339.
26. Hines, C.D., Frydrychowicz, A., Hamilton, G., et al. T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging 33 (2011), 873–881.
27. Permutt, Z., Le, T.A., Peterson, M.R., et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 36 (2012), 22–29.
28. Yokoo, T., Serai, S.D., Pirasteh, A., et al. Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis. Radiology, 2017, 170550.
29. Middleton, M.S., Heba, E.R., Hooker, C.A., et al. Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis. Gastroenterology 153 (2017), 753–761.
30. Middleton, M.S., Van Natta, M.L., Heba, E.R., et al. Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease. Hepatology, 2017.
31. Heba, E.R., Desai, A., Zand, K.A., et al. Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference. J Magn Reson Imaging 43 (2016), 398–406.